JP2025512953A5 - - Google Patents
Info
- Publication number
- JP2025512953A5 JP2025512953A5 JP2024559145A JP2024559145A JP2025512953A5 JP 2025512953 A5 JP2025512953 A5 JP 2025512953A5 JP 2024559145 A JP2024559145 A JP 2024559145A JP 2024559145 A JP2024559145 A JP 2024559145A JP 2025512953 A5 JP2025512953 A5 JP 2025512953A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- binding protein
- tumor
- immunoglobulin
- specifically binds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263329583P | 2022-04-11 | 2022-04-11 | |
| US63/329,583 | 2022-04-11 | ||
| PCT/EP2023/059278 WO2023198635A1 (en) | 2022-04-11 | 2023-04-06 | T cell binding proteins |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025512953A JP2025512953A (ja) | 2025-04-22 |
| JP2025512953A5 true JP2025512953A5 (enExample) | 2026-04-14 |
Family
ID=86226585
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024559145A Pending JP2025512953A (ja) | 2022-04-11 | 2023-04-06 | Ｔ細胞結合タンパク質 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20250346681A1 (enExample) |
| EP (1) | EP4508080A1 (enExample) |
| JP (1) | JP2025512953A (enExample) |
| CN (1) | CN118974091A (enExample) |
| WO (1) | WO2023198635A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111201030B (zh) | 2017-07-25 | 2024-11-01 | 真和制药有限公司 | 通过阻断tim-3和其配体的相互作用治疗癌症 |
| WO2020160156A2 (en) | 2019-01-30 | 2020-08-06 | Immutics, Inc. | Anti-gal3 antibodies and uses thereof |
| EP4157338A4 (en) | 2020-05-26 | 2024-11-13 | TrueBinding, Inc. | METHOD FOR TREATING INFLAMMATORY DISEASES BY GALECTIN-3 BLOCKING |
| GB2641580A (en) * | 2024-06-07 | 2025-12-10 | T Therapeutics Ltd | Tumour-transforming multispecific proteins |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5892019A (en) | 1987-07-15 | 1999-04-06 | The United States Of America, As Represented By The Department Of Health And Human Services | Production of a single-gene-encoded immunoglobulin |
| US5736137A (en) | 1992-11-13 | 1998-04-07 | Idec Pharmaceuticals Corporation | Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma |
| WO2016105450A2 (en) * | 2014-12-22 | 2016-06-30 | Xencor, Inc. | Trispecific antibodies |
| US20200157224A1 (en) * | 2017-06-25 | 2020-05-21 | Systimmune, Inc. | Multi-specific antibodies and methods of making and using thereof |
| KR102763369B1 (ko) * | 2017-06-25 | 2025-02-05 | 시스트이뮨, 인코포레이티드 | 다중-특이적 항체 및 이를 제조하는 방법 및 이의 용도 |
| US11773171B2 (en) * | 2017-12-19 | 2023-10-03 | Surrozen Operating, Inc. | WNT surrogate molecules and uses thereof |
| SG11202008474QA (en) * | 2018-03-27 | 2020-10-29 | Systimmune Inc | Guidance and navigation control proteins and method of making and using thereof |
-
2023
- 2023-04-06 US US18/854,215 patent/US20250346681A1/en active Pending
- 2023-04-06 JP JP2024559145A patent/JP2025512953A/ja active Pending
- 2023-04-06 CN CN202380032014.9A patent/CN118974091A/zh active Pending
- 2023-04-06 EP EP23719654.8A patent/EP4508080A1/en active Pending
- 2023-04-06 WO PCT/EP2023/059278 patent/WO2023198635A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2025512953A5 (enExample) | ||
| JP2022512653A5 (enExample) | ||
| JP2024532485A5 (enExample) | ||
| JP2022525478A5 (enExample) | ||
| JP2021525546A5 (enExample) | ||
| JP7399852B2 (ja) | 多重特異性抗体とその作製及び使用方法 | |
| JP2024023228A5 (enExample) | ||
| JP2018502050A5 (enExample) | ||
| RU2015144098A (ru) | Четырехвалентные биспецифические антитела | |
| JP2022527151A5 (enExample) | ||
| CN106659779A (zh) | 双特异性四价抗体及其制造和使用方法 | |
| JP2021512151A5 (enExample) | ||
| JP2024001073A5 (enExample) | ||
| JP2021531825A5 (enExample) | ||
| JP2022553922A5 (enExample) | ||
| JP2024507540A5 (enExample) | ||
| JP2019512207A5 (enExample) | ||
| JP2023524102A5 (enExample) | ||
| JP2023544143A5 (enExample) | ||
| JP2024116283A5 (enExample) | ||
| IL283279B2 (en) | Bi-specific conjugates | |
| JP2024515560A5 (enExample) | ||
| JP2025508317A5 (enExample) | ||
| JP2016529213A5 (enExample) | ||
| CN114786720B (zh) | TriAx抗体的组合物及其制备和使用方法 |